Skip to main content

Notable reduction in illegitimate integration mediated by a PPT-deleted, nonintegrating lentiviral vector

Publication ,  Journal Article
Kantor, B; Bayer, M; Ma, H; Samulski, J; Li, C; McCown, T; Kafri, T
Published in: Molecular Therapy
January 1, 2011

Nonintegrating lentiviral vectors present a means of reducing the risk of insertional mutagenesis in nondividing cells and enabling short-term expression of potentially hazardous gene products. However, residual, integrase-independent integration raises a concern that may limit the usefulness of this system. Here we present a novel 3′ polypurine tract (PPT)-deleted lentiviral vector that demonstrates impaired integration efficiency and, when packaged into integrase-deficient particles, significantly reduced illegitimate integration. Cells transduced with PPT-deleted vectors exhibited predominantly 1-long terminal repeat (LTR) circles and a low level of linear genomes after reverse transcription (RT). Importantly, the PPT-deleted vector exhibited titers and in vitro and in vivo expression levels matching those of conventional nonintegrating lentiviral vectors. This safer nonintegrating lentiviral vector system will support emerging technologies, such as those based on transient expression of zinc-finger nucleases (ZFNs) for gene editing, as well as reprogramming factors for inducing pluripotency. © The American Society of Gene & Cell Therapy.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Molecular Therapy

DOI

EISSN

1525-0024

ISSN

1525-0016

Publication Date

January 1, 2011

Volume

19

Issue

3

Start / End Page

547 / 556

Related Subject Headings

  • Biotechnology
  • 3206 Medical biotechnology
  • 3202 Clinical sciences
  • 3105 Genetics
  • 11 Medical and Health Sciences
  • 10 Technology
  • 06 Biological Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kantor, B., Bayer, M., Ma, H., Samulski, J., Li, C., McCown, T., & Kafri, T. (2011). Notable reduction in illegitimate integration mediated by a PPT-deleted, nonintegrating lentiviral vector. Molecular Therapy, 19(3), 547–556. https://doi.org/10.1038/mt.2010.277
Kantor, B., M. Bayer, H. Ma, J. Samulski, C. Li, T. McCown, and T. Kafri. “Notable reduction in illegitimate integration mediated by a PPT-deleted, nonintegrating lentiviral vector.” Molecular Therapy 19, no. 3 (January 1, 2011): 547–56. https://doi.org/10.1038/mt.2010.277.
Kantor B, Bayer M, Ma H, Samulski J, Li C, McCown T, et al. Notable reduction in illegitimate integration mediated by a PPT-deleted, nonintegrating lentiviral vector. Molecular Therapy. 2011 Jan 1;19(3):547–56.
Kantor, B., et al. “Notable reduction in illegitimate integration mediated by a PPT-deleted, nonintegrating lentiviral vector.” Molecular Therapy, vol. 19, no. 3, Jan. 2011, pp. 547–56. Scopus, doi:10.1038/mt.2010.277.
Kantor B, Bayer M, Ma H, Samulski J, Li C, McCown T, Kafri T. Notable reduction in illegitimate integration mediated by a PPT-deleted, nonintegrating lentiviral vector. Molecular Therapy. 2011 Jan 1;19(3):547–556.

Published In

Molecular Therapy

DOI

EISSN

1525-0024

ISSN

1525-0016

Publication Date

January 1, 2011

Volume

19

Issue

3

Start / End Page

547 / 556

Related Subject Headings

  • Biotechnology
  • 3206 Medical biotechnology
  • 3202 Clinical sciences
  • 3105 Genetics
  • 11 Medical and Health Sciences
  • 10 Technology
  • 06 Biological Sciences